Global Multi-Omics Market is set to be driven by high demands for Personalized Medicine and Technological Advancements

Omics has turned out to be a new mantra in molecular research. It is a field of study in biological sciences that ends in the suffix – omics. Many areas of research can be classified as omics such as genomics, transcriptomics, proteomics and metabolomics.

·        Genomics studies genes and their function. Genomics finds application in drug discovery and development, diagnostics & therapeutic decision-making, agriculture, animal research and other applications.

·        Transcriptomics studies mRNAs. It is widely used for clinical diagnostics, drug discovery, toxicogenomics and other applications.

·        Proteomics studies proteins. It is used for clinical diagnosis of cancer, infectious diseases, cardiovascular diseases, immune diseases, neurological disorders, diabetes, etc. and drug discovery.

·        Metabonomics studies small molecules involved in cellular metabolism. It is a powerful research tool that is currently being applied to various aspects of drug and biomarker discovery, toxicology research, nutrigenomics and other applications

Complete understanding of human health and diseases warrants interpretation of molecular intricacy and variations at multiple levels such as genome, transcriptome, proteome, and metabolome. With the advent of sequencing technology, biology has become increasingly reliant on data generated at these levels, which collectively is called as “Multi-Omics” data. Availability of Multi-Omics market data has revolutionized the field of medicine and biology. Data integration across different platforms (genomics, transcriptomics, proteomics and metabolomics) helps in understanding causal relationships across multiple levels of cellular organization in the Multi-Omics market. It offers unparalleled opportunities to understand the underlying biology of complex diseases such as cancer.

Competitive Landscape Analysis : Multi-Omics Market

Some of the key players operating in the Global Multi-Omics market are 10x Genomics, Bio-Techne Corporation, Fluidigm Corporation, Bio-Rad Laboratories, Inc., NanoString, Mission Bio, BD Biosciences, Thermo Fisher Scientific Inc., among others.

Single-Cell Analysis Enters the Era of Multi-Omics Market

A cell's condition can be defined by the interplay between its genome, epigenome, transcriptome, and proteome. Riding on the development of these omics technologies, Multi-Omics technologies for single cells have emerged that are able to capture multiple omic layers from the same cell. Profiling multiple omic layers makes it possible to capture a more complete set of information about each cell than is possible from any single omic layer alone. Single-cell Multi-Omics better reflects the complex network of interactions that are responsible for cellular functions and hence are considered more powerful than a stand-alone omics.

For Your Customized Research Requirements, Contact Us @ https://meditechinsights.com/contact-us/